Literature DB >> 23809903

Reduction in community-onset methicillin-resistant Staphylococcus aureus rates in an urban Canadian hospital setting.

A Wilmer1, E Lloyd-Smith2, M G Romney1, S Champagne1, T Wong1, W Zhang3, R Stenstrom4, M W Hull5.   

Abstract

Community-onset methicillin resistant Staphylococcus aureus (CO-MRSA) became a prominent cause of infection in North America in 2003, with a peak in the epidemic noted by multiple groups in the USA between 2005 and 2007. We reviewed rates of MRSA in two hospitals in Vancouver, Canada, to observe changes in epidemiology from 2003 to 2011. Episodes of emergency department (ED) MRSA bacteraemia and wounds were extracted from the laboratory database, with rates calculated per 10,000 ED visits. All cases were assumed to be community onset, as they were diagnosed in the ED. A peak in ED MRSA bacteraemias occurred in 2005, at 7·8/10,000 ED visits. By 2011, rates of ED bacteraemia declined significantly to 3·3/10,000 ED visits (P<or=0·03). MRSA wound rates peaked at 82·2 cases/10,000 ED visits in 2007 with a subsequent significant decline to 34·3 cases in 2011 (P=0·04). We have demonstrated a significant decline in CO-MRSA within our population, consistent with reports from the USA, suggesting a substantial change in the epidemiology of CO-MRSA in certain North American cities.

Entities:  

Mesh:

Year:  2013        PMID: 23809903      PMCID: PMC9151091          DOI: 10.1017/S0950268813001568

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  14 in total

Review 1.  Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus.

Authors:  Duarte C Oliveira; Alexander Tomasz; Hermínia de Lencastre
Journal:  Lancet Infect Dis       Date:  2002-03       Impact factor: 25.071

2.  Origins of community strains of methicillin-resistant Staphylococcus aureus.

Authors:  Edwin D Charlebois; Françoise Perdreau-Remington; Barry Kreiswirth; David R Bangsberg; Daniel Ciccarone; Binh A Diep; Valerie L Ng; Kimberly Chansky; Brian R Edlin; Brian Edlin; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2004-06-01       Impact factor: 9.079

3.  Methicillin-resistant Staphylococcus aureus strain USA300 is prevalent among hospital-onset cases in an urban Canadian setting.

Authors:  Amanda Wilmer; Elisa Lloyd-Smith; Marc Romney; Linda Hoang; Mark Hull; Sylvie Champagne
Journal:  Infect Control Hosp Epidemiol       Date:  2011-10-19       Impact factor: 3.254

4.  Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents.

Authors:  S Gupta; N Ferguson; R Anderson
Journal:  Science       Date:  1998-05-08       Impact factor: 47.728

Review 5.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

6.  Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users.

Authors:  E Lloyd-Smith; M W Hull; M W Tyndall; R Zhang; E Wood; J S G Montaner; T Kerr; M G Romney
Journal:  Epidemiol Infect       Date:  2010-03-05       Impact factor: 2.451

7.  Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010.

Authors:  Michael L Landrum; Charlotte Neumann; Courtney Cook; Uzo Chukwuma; Michael W Ellis; Duane R Hospenthal; Clinton K Murray
Journal:  JAMA       Date:  2012-07-04       Impact factor: 56.272

8.  Health care-associated invasive MRSA infections, 2005-2008.

Authors:  Alexander J Kallen; Yi Mu; Sandra Bulens; Arthur Reingold; Susan Petit; Ken Gershman; Susan M Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; William Schaffner; Priti R Patel; Scott K Fridkin
Journal:  JAMA       Date:  2010-08-11       Impact factor: 56.272

9.  Reduction of methicillin-resistant Staphylococcus aureus infection among veterans in Atlanta.

Authors:  Edward Stenehjem; Cortney Stafford; David Rimland
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-14       Impact factor: 3.254

10.  Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006.

Authors:  Eili Klein; David L Smith; Ramanan Laxminarayan
Journal:  Emerg Infect Dis       Date:  2009-12       Impact factor: 6.883

View more
  3 in total

1.  Performance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout Mutants.

Authors:  Rodrigo E Mendes; Amy A Watters; Paul R Rhomberg; David J Farrell; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2015-11-04       Impact factor: 5.948

2.  Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.

Authors:  Rodrigo E Mendes; Lalitagauri M Deshpande; Andrew J Costello; David J Farrell; Ronald N Jones; Robert K Flamm
Journal:  Microb Drug Resist       Date:  2015-07-31       Impact factor: 3.431

Review 3.  The Prevalence, Risk, and Management of Methicillin-Resistant Staphylococcus aureus Infection in Diverse Populations across Canada: A Systematic Review.

Authors:  Elena Mitevska; Britney Wong; Bas G J Surewaard; Craig N Jenne
Journal:  Pathogens       Date:  2021-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.